Fundraising Fox

Kjell Mortier

Investor

Fund Manager at Novalis Biotech

Ghent Metropolitan Area

About

Kjell Mortier (Pharm., PhD) is a Fund Manager at Novalis. He has around 20 years of experience in the biotech industry across scientific roles in large pharma and CDMO companies, including work on bioanalytical and immunogenicity aspects of (pre-)clinical programs at Ablynx (now part of Sanofi) and CMC-analytical support and technology evaluation at the CRO Eurofins. He also holds a certification in financial analysis from EHSAL Management School.

Invests in

Biotech

Experience

  1. Mobio ConsultOwner and managing directorcurrent2019 — present
  2. CLOUDS OF CAREBoard Observer2025 — 2026Belgium
  3. BioLizardBoard Member2021 — 2026Ghent
  4. Novalis BiotechFund Manager2019 — 2026
  5. RheumaFinderBoard Member2023 — 2026
  6. RheaVita BVBABoard Member2021 — 2026
  7. Epify BVBoard Member2019 — 2024
  8. BioLizardInterim Manager2019 — 2020Ghent, Belgium
  9. Eurofins Amatsigroup (CDMO)Principal Scientist Analytics2016 — 2019Gent Area, Belgium
  10. AblynxScientist2011 — 2016Zwijnaarde, Belgium
  11. AnaBioTecProject leader2010 — 2011Zwijnaarde, Belgium
  12. Baxter BioScienceContinuous Improvement Supervisor QC Lab2009 — 2010Lessines, Belgium
  13. WatersLC-MS application specialist2006 — 2009Zellik, Belgium
  14. Ghent University - Faculty of Pharmaceutical Sciences - ToxicologyPhD2000 — 2006

Education

  1. Guberna - Instituut voor BestuurdersBoard Effectiveness2025
  2. Guberna - Instituut voor BestuurdersDirector Effectiveness2024
  3. Vlerick Business SchoolVenture Capital and Private Equity
  4. EHSAL Management SchoolAccounting and Finance
  5. Ghent UniversityPharmaceutical Sciences1994 — 1999

Skills & more

Mass Spectrometry6LC-MS8HPLC2Chromatography7Proteomics2GLP3GMP2ELISA1Chemistry2Bioanalysis5Validation2Pharmacology3
+4 moreGas ChromatographyFDALife SciencesGood Laboratory Practice (GLP)

From Kjell's professional profile.

Same school

Shared employers

Colleagues at Novalis Biotech